Zeria Pharmaceutical Co Ltd
TSE:4559

Watchlist Manager
Zeria Pharmaceutical Co Ltd Logo
Zeria Pharmaceutical Co Ltd
TSE:4559
Watchlist
Price: 2 260 JPY 0.89% Market Closed
Market Cap: 99.6B JPY
Have any thoughts about
Zeria Pharmaceutical Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

4.9
Current
6.7
Median
13.7
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
4.9
=
Enterprise Value
86.8B JPY
/
EBITDA
17.7B JPY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
5.2
2-Years Forward
EV/EBITDA
5.1
3-Years Forward
EV/EBITDA
4.9

See Also

Discover More